 | • レポートコード：QY2207C0155 • 出版社/出版日：QYResearch / 2022年7月15日 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：3日） • 産業分類：化学＆材料 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界のドセタキセルAPIの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にドセタキセルAPIの世界市場のxxx％を占める「純度95％以上」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「ドセタキセル注射」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のドセタキセルAPIの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのドセタキセルAPI市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのドセタキセルAPI市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 ドセタキセルAPIのグローバル主要メーカーには、Phyton Biotech、ScinoPharm Taiwan、Aspen Biopharma Labs、Arca Pharmalabs、Fresenius Kabi、Dr. Reddy's Laboratories、Fujian South Pharmaceutical、Hainan Yew Pharmaceutical、Hubei Haosun Pharmaceutical、Tecoland、Qilu Pharmaceutial、Berr Chemicalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ドセタキセルAPI市場は、種類と用途によって区分されます。世界のドセタキセルAPI市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 純度95％以上、純度98％以上 【用途別セグメント】 ドセタキセル注射、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ドセタキセルAPI製品概要 - 種類別市場（純度95％以上、純度98％以上） - 用途別市場（ドセタキセル注射、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のドセタキセルAPI販売量予測2017-2028 - 世界のドセタキセルAPI売上予測2017-2028 - ドセタキセルAPIの地域別販売量 - ドセタキセルAPIの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ドセタキセルAPI販売量 - 主要メーカー別ドセタキセルAPI売上 - 主要メーカー別ドセタキセルAPI価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（純度95％以上、純度98％以上） - ドセタキセルAPIの種類別販売量 - ドセタキセルAPIの種類別売上 - ドセタキセルAPIの種類別価格 ・用途別市場規模（ドセタキセル注射、その他） - ドセタキセルAPIの用途別販売量 - ドセタキセルAPIの用途別売上 - ドセタキセルAPIの用途別価格 ・北米市場 - 北米のドセタキセルAPI市場規模（種類別、用途別） - 主要国別のドセタキセルAPI市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのドセタキセルAPI市場規模（種類別、用途別） - 主要国別のドセタキセルAPI市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のドセタキセルAPI市場規模（種類別、用途別） - 主要国別のドセタキセルAPI市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のドセタキセルAPI市場規模（種類別、用途別） - 主要国別のドセタキセルAPI市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのドセタキセルAPI市場規模（種類別、用途別） - 主要国別のドセタキセルAPI市場規模（トルコ、サウジアラビア） ・企業情報 Phyton Biotech、ScinoPharm Taiwan、Aspen Biopharma Labs、Arca Pharmalabs、Fresenius Kabi、Dr. Reddy's Laboratories、Fujian South Pharmaceutical、Hainan Yew Pharmaceutical、Hubei Haosun Pharmaceutical、Tecoland、Qilu Pharmaceutial、Berr Chemical ・産業チェーン及び販売チャネル分析 - ドセタキセルAPIの産業チェーン分析 - ドセタキセルAPIの原材料 - ドセタキセルAPIの生産プロセス - ドセタキセルAPIの販売及びマーケティング - ドセタキセルAPIの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ドセタキセルAPIの産業動向 - ドセタキセルAPIのマーケットドライバー - ドセタキセルAPIの課題 - ドセタキセルAPIの阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Docetaxel API Market
Due to the COVID-19 pandemic, the global Docetaxel API market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Purity Above 95% accounting for % of the Docetaxel API global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Docetaxel Injection segment is altered to an % CAGR throughout this forecast period.
China Docetaxel API market size is valued at US$ million in 2021, while the US and Europe Docetaxel API are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Docetaxel API landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Docetaxel API include Phyton Biotech, ScinoPharm Taiwan, Aspen Biopharma Labs, Arca Pharmalabs, Fresenius Kabi, Dr. Reddy’s Laboratories, Fujian South Pharmaceutical, Hainan Yew Pharmaceutical and Hubei Haosun Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Docetaxel API capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Docetaxel API by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Docetaxel API Scope and Segment
Docetaxel API market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Docetaxel API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Purity Above 95%
Purity Above 98%
Segment by Application
Docetaxel Injection
Others
By Company
Phyton Biotech
ScinoPharm Taiwan
Aspen Biopharma Labs
Arca Pharmalabs
Fresenius Kabi
Dr. Reddy’s Laboratories
Fujian South Pharmaceutical
Hainan Yew Pharmaceutical
Hubei Haosun Pharmaceutical
Tecoland
Qilu Pharmaceutial
Berr Chemical
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Docetaxel API Product Introduction
1.2 Market by Type
1.2.1 Global Docetaxel API Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Purity Above 95%
1.2.3 Purity Above 98%
1.3 Market by Application
1.3.1 Global Docetaxel API Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Docetaxel Injection
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Docetaxel API Production
2.1 Global Docetaxel API Production Capacity (2017-2028)
2.2 Global Docetaxel API Production by Region: 2017 VS 2021 VS 2028
2.3 Global Docetaxel API Production by Region
2.3.1 Global Docetaxel API Historic Production by Region (2017-2022)
2.3.2 Global Docetaxel API Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Docetaxel API Sales in Volume & Value Estimates and Forecasts
3.1 Global Docetaxel API Sales Estimates and Forecasts 2017-2028
3.2 Global Docetaxel API Revenue Estimates and Forecasts 2017-2028
3.3 Global Docetaxel API Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Docetaxel API Sales by Region
3.4.1 Global Docetaxel API Sales by Region (2017-2022)
3.4.2 Global Sales Docetaxel API by Region (2023-2028)
3.5 Global Docetaxel API Revenue by Region
3.5.1 Global Docetaxel API Revenue by Region (2017-2022)
3.5.2 Global Docetaxel API Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Docetaxel API Production Capacity by Manufacturers
4.2 Global Docetaxel API Sales by Manufacturers
4.2.1 Global Docetaxel API Sales by Manufacturers (2017-2022)
4.2.2 Global Docetaxel API Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Docetaxel API in 2021
4.3 Global Docetaxel API Revenue by Manufacturers
4.3.1 Global Docetaxel API Revenue by Manufacturers (2017-2022)
4.3.2 Global Docetaxel API Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Docetaxel API Revenue in 2021
4.4 Global Docetaxel API Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Docetaxel API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Docetaxel API Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Docetaxel API Sales by Type
5.1.1 Global Docetaxel API Historical Sales by Type (2017-2022)
5.1.2 Global Docetaxel API Forecasted Sales by Type (2023-2028)
5.1.3 Global Docetaxel API Sales Market Share by Type (2017-2028)
5.2 Global Docetaxel API Revenue by Type
5.2.1 Global Docetaxel API Historical Revenue by Type (2017-2022)
5.2.2 Global Docetaxel API Forecasted Revenue by Type (2023-2028)
5.2.3 Global Docetaxel API Revenue Market Share by Type (2017-2028)
5.3 Global Docetaxel API Price by Type
5.3.1 Global Docetaxel API Price by Type (2017-2022)
5.3.2 Global Docetaxel API Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Docetaxel API Sales by Application
6.1.1 Global Docetaxel API Historical Sales by Application (2017-2022)
6.1.2 Global Docetaxel API Forecasted Sales by Application (2023-2028)
6.1.3 Global Docetaxel API Sales Market Share by Application (2017-2028)
6.2 Global Docetaxel API Revenue by Application
6.2.1 Global Docetaxel API Historical Revenue by Application (2017-2022)
6.2.2 Global Docetaxel API Forecasted Revenue by Application (2023-2028)
6.2.3 Global Docetaxel API Revenue Market Share by Application (2017-2028)
6.3 Global Docetaxel API Price by Application
6.3.1 Global Docetaxel API Price by Application (2017-2022)
6.3.2 Global Docetaxel API Price Forecast by Application (2023-2028)
7 North America
7.1 North America Docetaxel API Market Size by Type
7.1.1 North America Docetaxel API Sales by Type (2017-2028)
7.1.2 North America Docetaxel API Revenue by Type (2017-2028)
7.2 North America Docetaxel API Market Size by Application
7.2.1 North America Docetaxel API Sales by Application (2017-2028)
7.2.2 North America Docetaxel API Revenue by Application (2017-2028)
7.3 North America Docetaxel API Sales by Country
7.3.1 North America Docetaxel API Sales by Country (2017-2028)
7.3.2 North America Docetaxel API Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Docetaxel API Market Size by Type
8.1.1 Europe Docetaxel API Sales by Type (2017-2028)
8.1.2 Europe Docetaxel API Revenue by Type (2017-2028)
8.2 Europe Docetaxel API Market Size by Application
8.2.1 Europe Docetaxel API Sales by Application (2017-2028)
8.2.2 Europe Docetaxel API Revenue by Application (2017-2028)
8.3 Europe Docetaxel API Sales by Country
8.3.1 Europe Docetaxel API Sales by Country (2017-2028)
8.3.2 Europe Docetaxel API Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Docetaxel API Market Size by Type
9.1.1 Asia Pacific Docetaxel API Sales by Type (2017-2028)
9.1.2 Asia Pacific Docetaxel API Revenue by Type (2017-2028)
9.2 Asia Pacific Docetaxel API Market Size by Application
9.2.1 Asia Pacific Docetaxel API Sales by Application (2017-2028)
9.2.2 Asia Pacific Docetaxel API Revenue by Application (2017-2028)
9.3 Asia Pacific Docetaxel API Sales by Region
9.3.1 Asia Pacific Docetaxel API Sales by Region (2017-2028)
9.3.2 Asia Pacific Docetaxel API Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Docetaxel API Market Size by Type
10.1.1 Latin America Docetaxel API Sales by Type (2017-2028)
10.1.2 Latin America Docetaxel API Revenue by Type (2017-2028)
10.2 Latin America Docetaxel API Market Size by Application
10.2.1 Latin America Docetaxel API Sales by Application (2017-2028)
10.2.2 Latin America Docetaxel API Revenue by Application (2017-2028)
10.3 Latin America Docetaxel API Sales by Country
10.3.1 Latin America Docetaxel API Sales by Country (2017-2028)
10.3.2 Latin America Docetaxel API Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Docetaxel API Market Size by Type
11.1.1 Middle East and Africa Docetaxel API Sales by Type (2017-2028)
11.1.2 Middle East and Africa Docetaxel API Revenue by Type (2017-2028)
11.2 Middle East and Africa Docetaxel API Market Size by Application
11.2.1 Middle East and Africa Docetaxel API Sales by Application (2017-2028)
11.2.2 Middle East and Africa Docetaxel API Revenue by Application (2017-2028)
11.3 Middle East and Africa Docetaxel API Sales by Country
11.3.1 Middle East and Africa Docetaxel API Sales by Country (2017-2028)
11.3.2 Middle East and Africa Docetaxel API Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Phyton Biotech
12.1.1 Phyton Biotech Corporation Information
12.1.2 Phyton Biotech Overview
12.1.3 Phyton Biotech Docetaxel API Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Phyton Biotech Docetaxel API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Phyton Biotech Recent Developments
12.2 ScinoPharm Taiwan
12.2.1 ScinoPharm Taiwan Corporation Information
12.2.2 ScinoPharm Taiwan Overview
12.2.3 ScinoPharm Taiwan Docetaxel API Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 ScinoPharm Taiwan Docetaxel API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 ScinoPharm Taiwan Recent Developments
12.3 Aspen Biopharma Labs
12.3.1 Aspen Biopharma Labs Corporation Information
12.3.2 Aspen Biopharma Labs Overview
12.3.3 Aspen Biopharma Labs Docetaxel API Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Aspen Biopharma Labs Docetaxel API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Aspen Biopharma Labs Recent Developments
12.4 Arca Pharmalabs
12.4.1 Arca Pharmalabs Corporation Information
12.4.2 Arca Pharmalabs Overview
12.4.3 Arca Pharmalabs Docetaxel API Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Arca Pharmalabs Docetaxel API Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Arca Pharmalabs Recent Developments
12.5 Fresenius Kabi
12.5.1 Fresenius Kabi Corporation Information
12.5.2 Fresenius Kabi Overview
12.5.3 Fresenius Kabi Docetaxel API Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Fresenius Kabi Docetaxel API Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Fresenius Kabi Recent Developments
12.6 Dr. Reddy’s Laboratories
12.6.1 Dr. Reddy’s Laboratories Corporation Information
12.6.2 Dr. Reddy’s Laboratories Overview
12.6.3 Dr. Reddy’s Laboratories Docetaxel API Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Dr. Reddy’s Laboratories Docetaxel API Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Dr. Reddy’s Laboratories Recent Developments
12.7 Fujian South Pharmaceutical
12.7.1 Fujian South Pharmaceutical Corporation Information
12.7.2 Fujian South Pharmaceutical Overview
12.7.3 Fujian South Pharmaceutical Docetaxel API Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Fujian South Pharmaceutical Docetaxel API Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Fujian South Pharmaceutical Recent Developments
12.8 Hainan Yew Pharmaceutical
12.8.1 Hainan Yew Pharmaceutical Corporation Information
12.8.2 Hainan Yew Pharmaceutical Overview
12.8.3 Hainan Yew Pharmaceutical Docetaxel API Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Hainan Yew Pharmaceutical Docetaxel API Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Hainan Yew Pharmaceutical Recent Developments
12.9 Hubei Haosun Pharmaceutical
12.9.1 Hubei Haosun Pharmaceutical Corporation Information
12.9.2 Hubei Haosun Pharmaceutical Overview
12.9.3 Hubei Haosun Pharmaceutical Docetaxel API Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Hubei Haosun Pharmaceutical Docetaxel API Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Hubei Haosun Pharmaceutical Recent Developments
12.10 Tecoland
12.10.1 Tecoland Corporation Information
12.10.2 Tecoland Overview
12.10.3 Tecoland Docetaxel API Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 Tecoland Docetaxel API Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Tecoland Recent Developments
12.11 Qilu Pharmaceutial
12.11.1 Qilu Pharmaceutial Corporation Information
12.11.2 Qilu Pharmaceutial Overview
12.11.3 Qilu Pharmaceutial Docetaxel API Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 Qilu Pharmaceutial Docetaxel API Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Qilu Pharmaceutial Recent Developments
12.12 Berr Chemical
12.12.1 Berr Chemical Corporation Information
12.12.2 Berr Chemical Overview
12.12.3 Berr Chemical Docetaxel API Sales, Price, Revenue and Gross Margin (2017-2022)
12.12.4 Berr Chemical Docetaxel API Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Berr Chemical Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Docetaxel API Industry Chain Analysis
13.2 Docetaxel API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Docetaxel API Production Mode & Process
13.4 Docetaxel API Sales and Marketing
13.4.1 Docetaxel API Sales Channels
13.4.2 Docetaxel API Distributors
13.5 Docetaxel API Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Docetaxel API Industry Trends
14.2 Docetaxel API Market Drivers
14.3 Docetaxel API Market Challenges
14.4 Docetaxel API Market Restraints
15 Key Finding in The Global Docetaxel API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer